摘要
地西他滨对骨髓增生异常综合征有肯定疗效,目前已成为治疗该病的一线用药。但是,如果地西他滨治疗的效果不肯定,下一步治疗的选择至关重要。我院最近对1例地西他滨治疗后进展为急性白血病的患者进行了自体造血干细胞移植,取得良好效果。
Decitabine is now as the first-line drug for the treatment of myelodysplastic syndrome because of its certain effect.However,if the effect is uncertain,the choice of next treatment is important.We recently transplanted autologous stem cell transplantation to a myelodysplastic syndrome patient progressing to acute leukemia,good results were achieved.
出处
《东南大学学报（医学版）》
CAS
2010年第6期608-610,共3页
Journal of Southeast University(Medical Science Edition)
基金
"十一五"国家科技支撑计划课题子课题(2008BAI61B02)
